Merck Aktie
111,00
EUR
-0,25
EUR
-0,22
%
Kursziele der Merck-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Merck-Aktie
Analyst | Kursziel | Abstand Kursziel | Datum | |
---|---|---|---|---|
UBS AG | - | - | 01.07.2025 | |
JP Morgan Chase & Co. | 155,00 EUR | +39,70% | 03.06.2025 | |
Deutsche Bank AG | 174,00 EUR | +56,83% | 30.05.2025 | |
Bernstein Research | 147,00 EUR | +32,49% | 27.05.2025 | |
Goldman Sachs Group Inc. | 165,00 EUR | +48,72% | 16.05.2025 | |
DZ BANK | - | - | 15.05.2025 | |
Barclays Capital | 160,00 EUR | +44,21% | 12.05.2025 | |
Jefferies & Company Inc. | 180,00 EUR | +62,24% | 14.11.2024 |
Werbung
Kursziele im Branchenvergleich
Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
---|---|---|---|---|---|
3M Co. | 0 | 0 | 0 | - | - |
Abbott Laboratories | 0 | 0 | 0 | - | - |
AstraZeneca PLC | 5 | 3 | 0 | 136,58 GBP | +32,68% |
BASF | 4 | 5 | 2 | 48,75 EUR | +14,73% |
Bayer | 2 | 7 | 0 | 26,86 EUR | -3,12% |
BB Biotech AG | 0 | 0 | 0 | - | - |
Beiersdorf AG | 8 | 1 | 2 | 138,90 EUR | +29,39% |
Biotest AG Vz. | 0 | 0 | 0 | - | - |
Bristol-Myers Squibb Co. | 0 | 0 | 0 | - | - |
Clorox Co., The | 0 | 0 | 0 | - | - |
Colgate-Palmolive Co. | 0 | 0 | 0 | - | - |
Eli Lilly | 1 | 0 | 0 | 994,00 USD | +28,80% |
Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
GSK PLC Registered Shs | 1 | 6 | 1 | 16,33 GBP | +21,14% |
H. B. Fuller Co. | 0 | 0 | 0 | - | - |
H&R GmbH & Co. KGaA | 0 | 1 | 0 | - | - |
Johnson & Johnson | 0 | 0 | 0 | - | - |
L'Oréal S.A. (L'Oreal, L Oreal) | 2 | 5 | 3 | 361,78 EUR | -0,23% |
LANXESS AG | 2 | 4 | 3 | 26,43 EUR | +3,16% |
Merck Co. | 0 | 0 | 0 | - | - |
Merck KGaA | 7 | 1 | 0 | 163,50 EUR | +47,36% |
Novartis AG | 3 | 5 | 1 | 99,75 CHF | +8,08% |
Pfizer Inc. | 3 | 4 | 0 | 29,17 USD | +19,21% |
Procter & Gamble Co. | 1 | 0 | 0 | 177,00 USD | +14,12% |
Reckitt Benckiser Plc | 4 | 6 | 0 | 58,22 GBP | +16,16% |
Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
Sanofi S.A. | 6 | 3 | 0 | 113,12 EUR | +35,62% |
STADA | 0 | 0 | 0 | - | - |
Takeda Pharmaceutical Co. Ltd. | 0 | 0 | 0 | - | - |
Unilever plc | 6 | 1 | 3 | 48,24 GBP | +8,65% |
WACKER CHEMIE AG | 4 | 4 | 0 | 77,00 EUR | +16,49% |